Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Antiaging Quantum Living (AAQL) EBT (2020 - 2025)

Antiaging Quantum Living (AAQL) has disclosed EBT for 6 consecutive years, with -$272113.0 as the latest value for Q4 2025.

  • Quarterly EBT fell 110.69% to -$272113.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$630239.0 through Dec 2025, up 21.47% year-over-year, with the annual reading at -$720409.0 for FY2025, 74.45% down from the prior year.
  • EBT hit -$272113.0 in Q4 2025 for Antiaging Quantum Living, down from -$51153.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of -$1520.0 in Q3 2022 to a low of -$272113.0 in Q4 2025.
  • Historically, EBT has averaged -$87750.7 across 5 years, with a median of -$29727.0 in 2023.
  • Biggest five-year swings in EBT: surged 78.07% in 2022 and later plummeted 3519.18% in 2024.
  • Year by year, EBT stood at -$19310.0 in 2021, then surged by 64.93% to -$6772.0 in 2022, then crashed by 1333.7% to -$97090.0 in 2023, then plummeted by 33.03% to -$129154.0 in 2024, then tumbled by 110.69% to -$272113.0 in 2025.
  • Business Quant data shows EBT for AAQL at -$272113.0 in Q4 2025, -$51153.0 in Q3 2025, and -$127372.0 in Q2 2025.